DrugPatentWatch Database Preview
Epirubicin hydrochloride - Generic Drug Details
What are the generic sources for epirubicin hydrochloride and what is the scope of epirubicin hydrochloride freedom to operate?
Epirubicin hydrochloride
is the generic ingredient in two branded drugs marketed by Pfizer Inc, Actavis Totowa, Akorn Inc, Cipla Ltd, Ebewe Pharma, Fresenius Kabi Usa, Hisun Pharm Hangzhou, Hospira, Impax Labs Inc, Mustafa Nevsat, Mylan Institutional, Mylan Labs Ltd, and West-ward Pharms Int, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for epirubicin hydrochloride. Eight suppliers are listed for this compound.
Summary for epirubicin hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 13 |
| NDAs: | 15 |
| Drug Master File Entries: | 9 |
| Suppliers / Packagers: | 8 |
| Bulk Api Vendors: | 57 |
| Clinical Trials: | 371 |
| Patent Applications: | 7,550 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | epirubicin hydrochloride at DailyMed |
Pharmacology for epirubicin hydrochloride
| Drug Class | Anthracycline Topoisomerase Inhibitor |
| Mechanism of Action | Topoisomerase Inhibitors |
Medical Subject Heading (MeSH) Categories for epirubicin hydrochloride
Synonyms for epirubicin hydrochloride
| (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside hydrochloride |
| (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside |
| (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside |
| (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride |
| (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride |
| (7S,9S)-7-[(2R,4S,5R,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione |
| (7S,9S)-7-[[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
| (8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride |
| (8S,10S)-10-(((2R,4S,5R,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione |
| (8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione |
| 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione |
| 15206-EP2269994A1 |
| 15206-EP2270008A1 |
| 15206-EP2270018A1 |
| 15206-EP2272827A1 |
| 15206-EP2275420A1 |
| 15206-EP2280012A2 |
| 15206-EP2281815A1 |
| 15206-EP2289892A1 |
| 15206-EP2292615A1 |
| 15206-EP2292617A1 |
| 15206-EP2295055A2 |
| 15206-EP2295416A2 |
| 15206-EP2295426A1 |
| 15206-EP2295427A1 |
| 15206-EP2298748A2 |
| 15206-EP2298764A1 |
| 15206-EP2298765A1 |
| 15206-EP2298768A1 |
| 15206-EP2298778A1 |
| 15206-EP2298780A1 |
| 15206-EP2301928A1 |
| 15206-EP2301933A1 |
| 15206-EP2305640A2 |
| 15206-EP2305642A2 |
| 15206-EP2305671A1 |
| 15206-EP2305689A1 |
| 15206-EP2308855A1 |
| 15206-EP2308861A1 |
| 15206-EP2311453A1 |
| 15206-EP2311808A1 |
| 15206-EP2311825A1 |
| 15206-EP2311827A1 |
| 15206-EP2311829A1 |
| 15206-EP2311840A1 |
| 15206-EP2311842A2 |
| 15206-EP2316832A1 |
| 15206-EP2316833A1 |
| 22966TX7J5 |
| 25316-40-9 |
| 33811-EP2275420A1 |
| 33811-EP2295055A2 |
| 33811-EP2295416A2 |
| 33811-EP2298748A2 |
| 33811-EP2298764A1 |
| 33811-EP2298765A1 |
| 33811-EP2305642A2 |
| 33811-EP2311453A1 |
| 3Z8479ZZ5X |
| 4-Epidoxorubicin |
| 4-Epidoxorubicin hydrochloride |
| 4'-epi-Adriamycin |
| 4'-epi-Adriamycin hydrochloride |
| 4'-epi-Doxorubicin |
| 4'-epi-DX |
| 4'-Epi-DXR |
| 4'-Epiadriamycin |
| 4'-epidoxorubicin |
| 4'-Epidoxorubicin hydrochloride |
| 4'-Epidoxorubicin|||4'-Epiadriamycin|||(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione |
| 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
| 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- |
| 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabinohexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- |
| 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
| 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)- |
| 56390-09-1 |
| 56390-09-1 (hydrochloride) |
| 56420-45-2 |
| 56420-45-2 (Parent) |
| 57918-25-9 |
| A831042 |
| AB00698552_15 |
| AB00698552_16 |
| AB00698552-11 |
| AB00698552-13 |
| AB00698552-14 |
| AC1L233G |
| AC1L26NP |
| AC1Q6JIV |
| Acid, 8 |
| AK326115 |
| AKOS027327569 |
| AKOS030526162 |
| AN-40147 |
| AOJJSUZBOXZQNB-VTZDEGQISA-N |
| BC208841 |
| BCP9000651 |
| BDBM43839 |
| BIFK0018 |
| BRN 1445813 |
| C11230 |
| CA010514 |
| CCG-100950 |
| CCRIS 2261 |
| CCRIS 4477 |
| CHEBI:47898 |
| CHEMBL1200981 |
| CHEMBL417 |
| CPD000466308 |
| CS-1773 |
| CS-2824 |
| CTK8F9465 |
| D02214 |
| D07901 |
| D0C9XJ |
| DB00445 |
| Doxorubicin-13CD3 (discontinued) |
| DR003222 |
| DTXSID0022987 |
| E-ADM |
| Ebewe (TN) |
| EINECS 260-145-2 |
| Ellence |
| Ellence (TN) |
| Epi-DX |
| Epiadriamycin |
| Epidoxorubicin |
| Epidoxorubicin hydrochloride |
| epirarubicin |
| Epirubicin |
| epirubicin (hydrochloride) |
| Epirubicin (INN) |
| Epirubicin (TN) |
| Epirubicin [INN:BAN] |
| Epirubicin Ebewe |
| Epirubicin HCl |
| Epirubicin HCl (4'-epidoxorubicin) |
| Epirubicin hydrochlorid |
| Epirubicin hydrochloride (JP17/USAN) |
| Epirubicin hydrochloride [USAN:JAN] |
| Epirubicin hydrochloride, >=90% (HPLC) |
| Epirubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Epirubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| EPIRUBICIN(Hydrochloride form) |
| Epirubicina |
| Epirubicina [INN-Spanish] |
| Epirubicina [Spanish] |
| Epirubicine |
| Epirubicine [French] |
| Epirubicine [INN-French] |
| Epirubicinum |
| Epirubicinum [INN-Latin] |
| Epirubicinum [Latin] |
| Epirubitec |
| farmarubicin |
| farmarubicine |
| Farmorubicin |
| Farmorubicin (TN) |
| Farmorubicina |
| FT-0630692 |
| HSDB 6962 |
| HY-13624 |
| HY-13624A |
| IMI 28 |
| IMI-28 |
| LS-187190 |
| LS-93989 |
| LS-93992 |
| MFCD00941448 |
| MLS000759412 |
| MLS001401404 |
| MolPort-003-666-844 |
| MWWSFMDVAYGXBV-FGBSZODSSA-N |
| NC00200 |
| NCGC00263918-04 |
| NSC 256942 |
| NSC-256942 |
| NSC-759195 |
| NSC256942 |
| NSC759195 |
| Pharmakon1600-01505708 |
| pharmarubicin |
| Pharmorubicin |
| Pharmorubicin (TN) |
| Pharmorubicin Pfs |
| Pidorubicin |
| Pidorubicina |
| Pidorubicina [INN-Spanish] |
| Pidorubicine |
| Pidorubicine [INN-French] |
| Pidorubicinum |
| Pidorubicinum [INN-Latin] |
| Q-101406 |
| Ridorubicin |
| s1223 |
| SAM001246559 |
| SBI-0206890.P001 |
| SCHEMBL3165 |
| SCHEMBL8582 |
| SMR000466308 |
| SR-01000763557 |
| SR-01000763557-3 |
| Triferric doxorubicin |
| UNII-22966TX7J5 |
| UNII-3Z8479ZZ5X |
| VA10821 |
| WP 697 |
| ZINC3938704 |
US Patents and Regulatory Information for epirubicin hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisun Pharm Hangzhou | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 090075-002 | Mar 25, 2010 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Hospira | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | POWDER;INTRAVENOUS | 050807-001 | Sep 15, 2006 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Mylan Institutional | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065371-001 | Nov 28, 2007 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Actavis Totowa | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065445-002 | Sep 18, 2008 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Fresenius Kabi Usa | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065411-002 | Aug 20, 2007 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| West-ward Pharms Int | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065289-002 | Jun 27, 2007 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Follow DrugPatentWatch: